by the year 2000 about half the patients will be adults. It has been achieved by the careful application of developing knowledge and of good clinical practice and by cooperation between specialists and primary care and the development of multidisciplinary teams rather than by any one dramatic scientific development. Recently, heart-lung and lung transplantation has proved successful for selected patients, and the future holds the prospect of curative gene therapy.
A survey of specialist services for patients with cystic fibrosis was undertaken in five disparate English regions and in Northern Ireland. The specific aims were to determine access to and availability of NHS specialist services for adults and childen with cystic fibrosis; variations within the United Kingdom; the impact of the NHS reforms; and current and future purchasing plans.
The total number of patients with cystic fibrosis in the United Kingdom is rising by 120 a year, mainly in the adult age group. Children born today with cystic fibrosis can expect an average of over 40 years of life, and childhood death from the disease is relatively rare. No significant differences in mortality were found between regions. An average district has 20-28 resident patients with cystic fibrosis, of whom five to ten will be adults; an average region has 350 resident patients with the disease, of whom 150 are adults.
The survey showed that a substantial number of patients receive a poor standard of care, whose main cause seems to lie in lack of knowledge. Improved outcome of treatment is associated with increasing advances in and complexity of treatment protocols. Doctors and nurses who care for children with leukaemia need to be very familiar not only with the children's problems but also with the problems of bone marrow failure induced by chemotherapy, and they need ready access to full support facilities including drug assays, central venous catheters, intravenous antibiotics, and blood products. Such facilities are expensive and their efficient use requires experience, training, and, above all, sufficient familiarity to maintain an appropriate level of expertise. Recognising this, district hospital consultants who previously treated children with leukaemia without reference to special centres, who saw only one or two new patients a year, have largely given up the practice. However, several larger district services offer local treatment to children on a "shared care" basis in collaboration with their regional leukaemia unit.
A survey was undertaken to define the existing organisation of treatment for childhood leukaemia and to see whether the 1990 reforms had disrupted it. Four disparate English regions were chosen, together with Wales and two sparsely populated Scottish health boards. The main questions were whether the NHS reforms had affected either patient referral patterns or resources available for treating childhood leukaemia. There was no evidence from any of the regions surveyed that pre-existing referral patterns are being influenced by any fallout from the internal market, but it is too soon to feel confident that changes will never occur.
One 1987-8, 1989-90, 1991-2, and 1992-3. Huge variations were disclosed in rates of CABG and PTCA among districts, for reasons which are complex and only partially understood; the variations cannot be explained on the basis of the availability of regional services. If purchasers were to continue to buy these services on the basis of historical activity, this inequity of provision would persist. The Department of Health set, in 1986, a national target to be achieved by 1990 of a minimum of 300 CABG procedures per million population.
The rates of CABG and PTCA in the NHS regions studied increased monotonically over the period of this inquiry, but only one region achieved the target of 300 per million, although two others came very close in 1992-3. The rate of increase has fallen as the national target has been approached. In 1991-2 rates of CABG varied ninefold and of PTCA 62-fold between the 42 districts in the study. By 1992-3 the variations had decreased to fivefold and 27-fold respectively.
Many patients endure long waiting times, particularly for CABG. One of the many reasons for this is delays caused by purchasers paying for fewer procedures than cardiologists deem clinically necessary. In this situation, access depends on contracted activity rather than clinical priority.
Conclusions
The four specialist services surveyed have characteristics likely to be found wherever patient numbers are too low and the need for clinical expertise too high for a service to be provided in every general acute hospital. The way in which each such specialist service can develop in harmony with the NHS reforms is bound to reflect its individual needs, as well as the contracting processes under which it is funded. Specific recommendations arising from consideration of each service are set out in the working groups' reports. All four reports have in common five key themes, as follows (box Many specialist services are not suited to full devolution of contracting to district health authorities or to case insensitive block contracts. Providers need contracts that both assure a level of core funding and are responsive to variations in the numbers of patients referred. The forthcoming abolition of regional health authorities will place the responsibility for this supradistrict dimension on the Management Executive's regional offices.
There was a general plea from purchasers and providers for national guidelines for model contracts for the different services. The neonatal intensive care and childhood leukaemia working groups recommend that their specialist centres could best operate and contract if they were subject to some form of nationally agreed accreditation system. This particular proposal would need national multidisciplinary groups additional to present arrangements, but the merits of the proposals are strong.
EFFECTS OF NHS REFORMS
Much of the data collected relate to the first full year of the NHS reforms, with a snapshot of the position early in the second year. In these early days many of the strengths (and there are many) and weaknesses which the working groups identified in their specialist services predate the NHS reforms. Inevitably anxieties about the future have been expressed by purchasers, providers and "performers" (that is, clinicians), and patients.
In neonatal intensive care there was some reduction of access and more "transfers" in 1991-2 than in the previous year, but this was not attributable to reorganisation. Some patients with cystic fibrosis and parents noted greater difficulty in obtaining supplies of essential medication and had increasing concerns over cost. For childhood leukaemia there had been no apparent charge. For CABG/PTCA some providers were beginning to see adverse effects on waiting times and on equity of provision, particularly towards the end of the financial year. However, these observations do not so far indicate significant trends.
FUTURE WORK
A considerable amount of valuable and interesting data has been assembled which justifies regular review and follow up and research is recommended. In two to three years' time the NHS reforms will be more firmly established and valid comparisons will be possible. This paper is based entirely on the reports prepared by Professor John Richmond and his working group chairmen. The work described, and many of the words used, are theirs, and the author is pleased to acknowledge them.
